Australia Judge Rejects $527 Million Settlement Over Vioxx
This article was originally published in PharmAsia News
Executive Summary
An Australian court rejected a class-action settlement that would have had Merck pay 1,700 plaintiffs a maximum of less than $2,000 each for damages caused by its since-withdrawn Vioxx (rofecoxib) arthritis drug.